An inverse agonist of ERRγ, GSK5182, increases iodine uptake and enhances membrane localization of NIS in anaplastic thyroid cancer cells [46]. Here, SLC5A5 is linked to thyroid gland undifferentiated (anaplastic) carcinoma.